Abaxis gets FDA clearance for CRP test

01/21/2010 | ABC News

Abaxis, a provider of blood analysis systems, said it has obtained an FDA marketing clearance for its C-Reactive Protein assay. The test, which complements the company's Piccolo Xpress system, can detect infections, inflammatory diseases, tissue injuries and abnormal cell growth in under 12 minutes, Abaxis said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC